Tag: Bria-IMT™

February 11, 2020

BriaCell Announces Grant to Investigator Dr. Saveri Bhattacharya at Sidney Kimmel Cancer Center – Jefferson Health

BriaCell Therapeutics Corp. announced that Dr. Saveri Bhattacharya has been selected to receive support from the Merck Investigator Studies Program.
January 28, 2020

BriaCell’s Clinical Data Accepted to be Presented at the Annual Symposium of Society of Surgical Oncology 2020 in Boston

BriaCell is pleased to announce that the data of its clinical studies will be presented the at the Annual Symposium...
January 22, 2020

BriaCell Invited to Present at Mount Sinai’s Frontiers in Academic Pathology Symposium at The New York Academy of Medicine

BriaCell announced that it will present at the “Frontiers in Academic Pathology” symposium, hosted by the Icahn School of Medicine...
January 13, 2020

BriaCell Provides Update on Remarkable Responder

BriaCell is pleased to provide an update on the top responder in the combination study of Bria-IMT™, with Incyte’s INCMGA00012,...
January 9, 2020

BriaCell Outlines New High Responding Patient Group ‘Biomarker’ Based on Cancer Grade

BriaCell is pleased to announce it has identified a new group of patients with high levels of clinical benefit in...
January 7, 2020

BriaCell Ready to Seek Partners for Breast Cancer Treatment Bria-IMT

BriaCell Therapeutics Corp. (TSX:BCT,OTCQB:BCTXF) was recently featured in an article by BioTuesdays regarding the company's leading immunotherapy, Bria-IMT.
January 3, 2020

BriaCell Completes Share Consolidation

BriaCell Therapeutics Corp. is pleased to announce that it has completed its previously announced consolidation of the common shares of...